Sysmex ADR Gross Profit 2016-2024 | SSMXY
Sysmex ADR annual/quarterly gross profit history and growth rate from 2016 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Sysmex ADR gross profit for the quarter ending September 30, 2024 was $M, a 100% decline year-over-year.
- Sysmex ADR gross profit for the twelve months ending September 30, 2024 was $0.752B, a 43.54% decline year-over-year.
- Sysmex ADR annual gross profit for 2024 was $1.606B, a 0.43% increase from 2023.
- Sysmex ADR annual gross profit for 2023 was $1.599B, a 5.73% decline from 2022.
- Sysmex ADR annual gross profit for 2022 was $1.696B, a 22.02% increase from 2021.
| Sysmex ADR Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,606 |
| 2023 | $1,599 |
| 2022 | $1,696 |
| 2021 | $1,390 |
| 2020 | $1,466 |
| 2019 | $1,454 |
| 2018 | $1,500 |
| 2017 | $1,266 |
| 2016 | $1,337 |
| Sysmex ADR Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | $384 |
| 2023-12-31 | |
| 2023-06-30 | $368 |
| 2022-06-30 | $331 |
| 2021-06-30 | $381 |
| 2020-06-30 | $285 |
| 2019-06-30 | $336 |
| 2018-06-30 | $346 |
| 2017-06-30 | $314 |
| 2016-06-30 | $320 |
| 2016-03-31 | $585 |
| 2015-12-31 | $524 |
| 2015-09-30 | $526 |
| 2015-06-30 | $478 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.739B | $3.197B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.963B | 25.00 |
| Intuitive Surgical (ISRG) | United States | $191.657B | 100.20 |
| Edwards Lifesciences (EW) | United States | $43.285B | 27.49 |
| Alcon (ALC) | Switzerland | $42.325B | 28.32 |
| IQVIA Holdings (IQV) | United States | $36.881B | 20.32 |
| IDEXX Laboratories (IDXX) | United States | $36.416B | 42.88 |
| DexCom (DXCM) | United States | $31.017B | 46.71 |
| Waters (WAT) | United States | $23.177B | 34.27 |
| STERIS (STE) | Ireland | $21.145B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.889B | 0.00 |
| Hologic (HOLX) | United States | $17.436B | 18.83 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.025B | 14.40 |
| Globus Medical (GMED) | United States | $11.287B | 28.58 |
| Masimo (MASI) | United States | $9.351B | 45.25 |
| Penumbra (PEN) | United States | $9.298B | 91.08 |
| Teleflex (TFX) | United States | $8.663B | 13.82 |
| Glaukos (GKOS) | United States | $7.520B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.758B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.684B | 26.55 |
| Veracyte (VCYT) | United States | $3.331B | 99.95 |
| Inari Medical (NARI) | United States | $3.223B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.717B | 15.69 |
| Nihon Kohden (NHNKY) | Japan | $2.514B | 19.10 |
| TransMedics (TMDX) | United States | $2.315B | 73.39 |
| Elekta AB (EKTAY) | Sweden | $2.239B | 20.13 |
| Tandem Diabetes Care (TNDM) | United States | $2.221B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.853B | 9.68 |
| RxSight (RXST) | United States | $1.579B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.369B | 0.00 |
| Artivion (AORT) | United States | $1.250B | 82.86 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.025B | 0.00 |
| Paragon 28 (FNA) | United States | $0.879B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.709B | 0.00 |
| IRadimed (IRMD) | United States | $0.701B | 37.88 |
| Mesa Laboratories (MLAB) | United States | $0.700B | 16.50 |
| AxoGen (AXGN) | United States | $0.653B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.641B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.496B | 29.18 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.460B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.449B | 24.29 |
| Delcath Systems (DCTH) | United States | $0.373B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.231B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.212B | 0.00 |
| Accuray (ARAY) | United States | $0.208B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.159B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.145B | 15.56 |
| Spectral Diagnostics (EDTXF) | Canada | $0.106B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.093B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.092B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.084B | 0.00 |
| InspireMD (NSPR) | Israel | $0.082B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.035B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |